Peter Parham Selected Research

Parkinson Disease (Parkinson's Disease)

1/2020	Killer Cell Immunoglobulin-like Receptor Variants Are Associated with Protection from Symptoms Associated with More Severe Course in Parkinson Disease.
1/2019	A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Parham Research Topics

Disease

12	Infections 11/2018 - 05/2003
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 06/2007
6	Neoplasms (Cancer) 01/2022 - 01/2002
5	Leukemia 01/2021 - 05/2003
4	Virus Diseases (Viral Diseases) 01/2018 - 01/2012
3	Malaria 01/2023 - 01/2012
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2011 - 06/2007
2	Parkinson Disease (Parkinson's Disease) 01/2020 - 01/2019
2	Persistent Infection 10/2015 - 11/2014
2	Pre-Eclampsia (Preeclampsia) 01/2015 - 11/2010
2	Cerebral Malaria 10/2013 - 01/2012
2	Communicable Diseases (Infectious Diseases) 06/2011 - 08/2010
2	HIV Infections (HIV Infection) 01/2011 - 06/2007
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Behcet Syndrome (Behcet's Syndrome) 01/2019
1	Rheumatoid Arthritis 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Drug Hypersensitivity (Drug Allergy) 11/2018
1	Drug-Related Side Effects and Adverse Reactions 11/2018
1	Cytomegalovirus Infections (Inclusion Disease) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Disease Resistance 10/2013
1	Myeloid Leukemia (Leukemia, Myelocytic) 06/2007
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2007
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2007
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2007
1	Human Influenza (Influenza) 03/2007
1	Vaccinia 01/2006
1	Autoimmune Diseases (Autoimmune Disease) 03/2005
1	Disease Susceptibility (Diathesis) 02/2005
1	Lymphoma (Lymphomas) 02/2003

Drug/Important Bio-Agent (IBA)

9	KIR ReceptorsIBA 01/2020 - 06/2006
9	LigandsIBA 05/2014 - 05/2003
7	HLA-B Antigens (HLA-B)IBA 01/2023 - 06/2007
7	HLA-C Antigens (HLA-C)IBA 01/2018 - 11/2010
4	Peptides (Polypeptides)IBA 01/2023 - 01/2017
4	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 05/2003
4	EpitopesIBA 01/2019 - 01/2015
4	HLA Antigens (Human Leukocyte Antigens)IBA 11/2018 - 05/2003
3	AntigensIBA 01/2023 - 01/2018
3	CytokinesIBA 01/2022 - 01/2012
3	Natural Killer Cell ReceptorsIBA 10/2015 - 03/2007
2	VaccinesIBA 01/2019 - 11/2014
2	NK Cell Lectin-Like Receptor Subfamily CIBA 01/2018 - 01/2006
2	Histocompatibility Antigens Class IIBA 05/2015 - 01/2002
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2023
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Valine (L-Valine)FDA Link 01/2019
1	HLA-B57 antigenIBA 11/2018
1	Viral AntigensIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 06/2007
1	N 556IBA 06/2007
1	Proteins (Proteins, Gene)FDA Link 03/2007
1	Poly I-CIBA 03/2007
1	Hemagglutinins (Hemagglutinin)IBA 03/2007
1	Carrier Proteins (Binding Protein)IBA 03/2007

Therapy/Procedure

12	Transplantation 01/2021 - 05/2003
6	Cell Transplantation 01/2021 - 02/2003
2	Immunotherapy 01/2022 - 08/2016
2	Therapeutics 01/2019 - 11/2014
2	Donor Selection 05/2014 - 10/2010
1	Hematopoietic Stem Cell Transplantation 01/2016
1	Stem Cell Transplantation 03/2005
1	Homologous Transplantation 02/2005